Fusion Antibodies is a CRO that offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development.
Latest News
- Final results
14 September 2026 - Grant of Canadian Patent for OptiMAL®
09 September 2026 - Notice of results
09 September 2026
Investor Alert
Sign up for Investor Alerts »